Effective coverage measurement in maternal, newborn, child, and adolescent health and nutrition: progress, future prospects, and implications for quality health systems.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
05 2020
Historique:
received: 23 10 2019
revised: 04 03 2020
accepted: 09 03 2020
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 28 8 2020
Statut: ppublish

Résumé

Intervention coverage-the proportion of the population with a health-care need who receive care-does not account for intervention quality and potentially overestimates health benefits of services provided to populations. Effective coverage introduces the dimension of quality of care to the measurement of intervention coverage. Many definitions and methodological approaches to measuring effective coverage have been developed, resulting in confusion over definition, calculation, interpretation, and monitoring of these measures. To develop a consensus on the definition and measurement of effective coverage for maternal, newborn, child, and adolescent health and nutrition (MNCAHN), WHO and UNICEF convened a group of experts, the Effective Coverage Think Tank Group, to make recommendations for standardising the definition of effective coverage, measurement approaches for effective coverage, indicators of effective coverage in MNCAHN, and to develop future effective coverage research priorities. Via a series of consultations, the group recommended that effective coverage be defined as the proportion of a population in need of a service that resulted in a positive health outcome from the service. The proposed effective coverage measures and care cascade steps can be applied to further develop effective coverage measures across a broad range of MNCAHN services. Furthermore, advances in measurement of effective coverage could improve monitoring efforts towards the achievement of universal health coverage.

Identifiants

pubmed: 32353320
pii: S2214-109X(20)30104-2
doi: 10.1016/S2214-109X(20)30104-2
pmc: PMC7196884
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e730-e736

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2020 This is an Open Access article published under the CC BY-NC-ND 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. Published by Elsevier Ltd.. All rights reserved.

Références

Bull World Health Organ. 1978;56(2):295-303
pubmed: 96953
Lancet Glob Health. 2018 Feb;6(2):e152-e168
pubmed: 29248365
BMJ Open. 2018 Jul 30;8(7):e019079
pubmed: 30061428
Soc Sci Med. 1983;17(3):147-61
pubmed: 6836349
Trop Med Int Health. 2017 Apr;22(4):442-453
pubmed: 28094465
Med Care. 1981 Feb;19(2):127-40
pubmed: 7206846
BMC Health Serv Res. 2018 Nov 23;18(1):886
pubmed: 30470214
BMJ Glob Health. 2017 Sep 4;2(3):e000424
pubmed: 29632704
Health Aff (Millwood). 2009 Nov-Dec;28(6):1677-87
pubmed: 19887408
BMJ Glob Health. 2019 Jun 24;4(Suppl 4):e001297
pubmed: 31297252
PLoS Med. 2019 Aug 7;16(8):e1002879
pubmed: 31390364
J Glob Health. 2018 Jun;8(1):010601
pubmed: 29497508
Soc Sci Med. 2005 Jul;61(1):97-109
pubmed: 15847965
PLoS Med. 2014 Sep 22;11(9):e1001730
pubmed: 25243780
Bull World Health Organ. 2017 Oct 1;95(10):683-694
pubmed: 29147041
BMJ. 2018 Jul 30;362:k2993
pubmed: 30061095
PLoS One. 2015 Jul 02;10(7):e0130697
pubmed: 26136239
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Lancet. 2006 Nov 11;368(9548):1729-41
pubmed: 17098091
Vaccine. 2019 Sep 3;37(37):5525-5534
pubmed: 31400910

Auteurs

Andrew D Marsh (AD)

Baltimore, MD, USA.

Moise Muzigaba (M)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Theresa Diaz (T)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland. Electronic address: tdiaz@who.int.

Jennifer Requejo (J)

Division of Data, Analysis, Planning and Monitoring, United Nations Children's Fund, Headquarters, New York, NY, USA.

Debra Jackson (D)

Health Division, United Nations Children's Fund, Headquarters, New York, NY, USA; School of Public Health, University of the Western Cape, Cape Town, South Africa.

Doris Chou (D)

Department of Sexual and Reproductive Health and Research including the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.

Jenny A Cresswell (JA)

Department of Sexual and Reproductive Health and Research including the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland.

Regina Guthold (R)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Allisyn C Moran (AC)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Kathleen L Strong (KL)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Anshu Banerjee (A)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Agnès Soucat (A)

Department of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH